CBD bioavailability: absorption, efficacy, and determining factors

The bioavailability of CBD is a key element in understanding its true effectiveness. Two products containing the same amount of cannabidiol can produce very different effects depending on how they are administered and absorbed by the body.

Bioavailability refers to the percentage of active substance that actually reaches the bloodstream after administration. In other words, it's not the dose consumed that matters, but the dose that is actually absorbed and available to interact with the endocannabinoid system.

Understanding this concept allows for better interpretation:

• The differences between oils, flowers, capsules, and vaping
• Variations in intensity and duration
• The impact of liver metabolism
• Optimizing formulations

Let's get into the full scientific analysis.

1. Scientific definition of bioavailability

Bioavailability is expressed as a percentage.

If you consume 100 mg of CBD orally and only 10 mg reach systemic circulation, the bioavailability is 10%.

It depends on several factors:

• Method of administration
• Individual metabolism
• Liposolubility
• Interaction with liver enzymes
• Product formulation

CBD has variable bioavailability depending on the route used.

2. Oral bioavailability

When CBD is ingested (capsule, food, infusion), it passes through:

1. The digestive system

2. Intestinal absorption

3. The liver (first-pass hepatic effect)

The liver metabolizes a significant portion of CBD before it reaches the general circulation.

Average estimate:
6% to 19%, according to studies

This means that a large part is transformed before action is taken.

The effect is slower, but often more prolonged.

3. Hepatic first-pass effect

The key phenomenon explaining the low oral bioavailability is called the first-pass effect.

After intestinal absorption, CBD is transported to the liver via the portal vein.

The CYP450 enzymes immediately begin its transformation.

Result:
A significant fraction is metabolized before reaching systemic circulation.

That is why sublingual oils were developed.

4. Sublingual bioavailability

When CBD oil is placed under the tongue:

• Part of it passes directly through the oral mucosa.
• It enters the bloodstream without immediately passing through the liver.

This helps to partially avoid the first-pass effect.

Average estimate:
12% to 35% depending on usage conditions

The time the device is held under the tongue strongly influences absorption.

5. Bioavailability by inhalation

Inhalation (vaporization) allows CBD to pass through the lungs.

The pulmonary alveoli provide:

• Large exchange surface area
• Rapid absorption
• Direct access to the bloodstream

Average estimate
: Up to 30% or more depending on the technique

The effects are rapid, but the duration is generally shorter.

6. Skin bioavailability

Topical products (creams, balms) act primarily at the local level.

Systemic penetration is limited.

Systemic bioavailability is low, but the local effect can be significant depending on the formulation.

7. Factors influencing absorption

Several factors affect the bioavailability of CBD.

Diet:
Taking it with a meal rich in fat may increase oral absorption.

Body weight:
The liposolubility of CBD influences its distribution in adipose tissues.

Formulation:
Lipid solutions improve absorption.

Product quality:
Purity and stability influence the quantity actually available.

8. Liposolubility and absorption

CBD is lipophilic.

It dissolves better in fats than in water.

Oils (MCT, hemp oil, olive oil) improve its solubility and facilitate its transport in the body.

This property explains why oils are the most widespread form.

9. Nano-emulsions and advanced technologies

Some modern formulations use:

• Nanoemulsions
• Lipid encapsulation
• Micellar systems

These technologies aim to improve oral bioavailability by reducing particle size.

The goal is to increase the fraction that is actually absorbed.

10. Onset of effects

Inhalation method.
Effects within minutes.

Sublingual route
15 to 45 minutes

Oral administration,
30 to 120 minutes

The speed depends directly on the route of administration.

11. Duration of action

Inhalation:
Shorter Effects

Sublingual
Intermediate duration

Oral
use: Longer-lasting effects due to gradual metabolism

Bioavailability influences not only the intensity, but also the duration.

12. Inter-individual variability

Bioavailability varies depending on:

• Liver enzyme activity
• Genetics
• Digestive status
• Age
• Frequency of use

Two people taking the same dose can absorb different amounts.

13. Interaction with hepatic metabolism

The lower the bioavailability, the greater the hepatic transformation.

The first-pass effect reduces the active fraction.

Routes partially bypassing the liver increase bioavailability.

14. Importance for regulatory compliance

Good bioavailability allows for:

• Efficacy at lower doses
• Improved predictability
• Analytical stability

Within a strict European framework, mastery of formulations is essential.

15. Overall Summary

The bioavailability of CBD depends on:

• Route of administration
• First-pass hepatic metabolism
• Lipid formulation
• Individual factors

On average:

Oral route
6 to 19%

Sublingual route
12 to 35%

Inhalation
Up to 30% or more

Understanding bioavailability allows for a correct interpretation of the differences between products.

FAQ

Is CBD better absorbed with food
? Yes, especially with lipids.

Why are oils popular?
Because they improve solubility and absorption.

Is inhalation more effective?
It offers rapid absorption, but a shorter duration.

Encyclopedic perspective

The bioavailability of CBD relates to:

• Molecular chemistry
• Hepatic metabolism
• Formulation technology
• User experience

It forms a bridge between pharmacological science and practice.